A total of 15 families were investigated: probands with insulin-dependent diabetes mellitus and their relatives of the 1st degree of progeny (43 persons) in order to study the distribution of HLA antigens and their interrelationship with the gravity of a course of diabetes mellitus and the type of GTT. Antigens DR3 and/or DR4 were revealed in 93% of probands, especially in heterozygous patients (57.1%). A low level of C-peptide (0.21 +/- 0.03 ng/ml) was noted in most of the probands excluding 3 patients with nephropathy. Distinct relationship of antigens DR3 and DR4 with a clinical course of disease and its severity was undetectable. Antigens DR3 or/and DR4 were detected in 96% of the relatives with the prevalence of antigen DR4 (in 54.2%). During GTT normal tolerance was observed in 82.1% (23 persons), disorders were noted in 4, insulin-dependent diabetes mellitus--in one. Most of the relatives (82.6%) with normal glucose tolerance had antigens DR3 and/or DR4. Irrespective of the type of DR antigens the probands' relatives were characterized by moderate hyperinsulinism (by the results of IRI and C-peptide of blood serum).
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial.
Int J Mol Sci
January 2025
Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, 581 83 Linköping, Sweden.
Immunotherapies aimed at preserving residual beta cell function in type 1 diabetes have been successful, although the effect has been limited, or raised safety concerns. Transient effects often observed may necessitate redosing to prolong the effect, although this is not always feasible or safe. Treatment with intralymphatic GAD-alum has been shown to be tolerable and safe in persons with type 1 diabetes and has shown significant efficacy to preserve C-peptide with associated clinical benefit in individuals with the human leukocyte antigen DR3DQ2 haplotype.
View Article and Find Full Text PDFCationic pH-sensitive liposomes as tuberculosis subunit vaccine delivery systems: Effect of liposome composition on cellular innate immune responses.
Int Immunopharmacol
January 2025
Leiden University Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), The Netherlands.
Article Synopsis
- - Tuberculosis (TB) is a critical global health issue, and there's an urgent need for effective vaccines; CD8 T-cells, along with CD4 T-cells, are essential for fighting TB.
- - The study investigates pH-sensitive liposomes as a delivery system for a multi-stage protein vaccine (Ag85b-ESAT6-Rv2034) against TB, aiming to enhance CD8 T-cell responses through improved antigen presentation.
- - Results show that these liposomes are successfully taken up by immune cells and promote the activation of T-cells, indicating they could be promising candidates for developing effective TB vaccines.
Genetic Discovery and Risk Prediction for Type 1 Diabetes in Individuals Without High-Risk HLA-DR3/DR4 Haplotypes.
Diabetes Care
February 2025
Department of Pediatrics, University of California, San Diego, La Jolla, CA.
Article Synopsis
- The study investigates type 1 diabetes (T1D) in patients without high-risk HLA-DR3 or -DR4 haplotypes, identifying genetic factors and improving risk prediction for this group.
- Researchers analyzed data from 12,316 non-DR3/DR4 individuals, discovering 18 T1D risk variants that affect disease development differently based on HLA status and showing a greater polygenic burden for non-DR3/DR4 patients.
- A newly developed genetic risk score (GRS) significantly outperformed existing scores in predicting T1D for those without DR3/DR4, highlighting the need for tailored approaches in understanding and predicting the disease.
In silicon desinging of RANKL-targeting vaccine for protection of osteoporosis based on the epitope of Denosumab.
Int Immunopharmacol
January 2025
Orthopaedic Centre, The University of Hong Kong Shenzhen Hospital, Shenzhen, Guangdong 518000, China. Electronic address:
Background: Life quality of osteoporosis patients is affected significantly due to the severely complications of fracture and pain. RANKL, indicated as the key mediator of osteoporosis, plays a pathogenic role of osteoclasts induction. To target this program, two medications, bisphosphonate and Denosumab, were developed and achieved remarkable advantages in clinics.
View Article and Find Full Text PDFType 1 Diabetes Genetic Risk Contributes to Phenotypic Presentation in Monogenic Autoimmune Diabetes.
Diabetes
February 2025
Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, U.K.
There is variability in early-onset autoimmune diabetes presentation in individuals with monogenic autoimmunity; the mechanism(s) underlying this is unclear. We examined whether type 1 diabetes (T1D) polygenic risk contributes to clinical phenotype in monogenic autoimmune diabetes. Individuals with monogenic autoimmune diabetes had higher T1D genetic risk scores compared with control cohorts, driven largely by increased presence of T1D-risk DR3-DQ2 haplotype.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!